RECKITT
BENCKISER GROUP PLC
SHARE
BUYBACK PROGRAMME -
COMPLETION OF FIRST TRANCHE AND COMMENCEMENT OF SECOND
TRANCHE
Reckitt Benckiser Group plc
("Reckitt" or the
"Company") confirms
the successful completion of the first
tranche of £250m (the "First Tranche") of its £1 billion share
buyback programme (the "Programme") announced on 25 October
2023.
Under the First Tranche, between 30
October 2023 and 30 January 2024, the Company has
purchased 4,581,991 ordinary shares of 10p each (the
"Ordinary Shares") at an
average price of £54.5614, and which are now held in
treasury.
Further to the announcement on 20
December 2023, the Company confirms that the second tranche of the
Programme (the "Second
Tranche") to return a further up to
£250 million of capital to shareholders, will commence on 1
February 2024 and will end on or before 10 May
2024. As previously announced, the purpose of the
Second Tranche is to reduce the share capital of the Company.
The Second Tranche will take place within the
limitations of the authority granted to the Board
by shareholders at the Company's Annual General
Meeting on 3 May 2023. Pursuant to that
authority, the maximum number of shares which remain available for
purchase under the Second Tranche is 67,008,009.
As previously announced, Reckitt has
entered into a non-discretionary agreement
with Merrill Lynch International ("MLI") under which it has issued an
irrevocable instruction to MLI to manage the
Second Tranche of the Programme. MLI will, acting as riskless
principal, purchase Ordinary Shares for an aggregate purchase price
of no greater than £250 million and will simultaneously sell such
Ordinary Shares on to the Company. To the extent permitted by law,
Ordinary Shares purchased under the Second Tranche of the Programme
will be held in treasury.
Any further tranches of the
Programme, which may be conducted after completion of the Second
Tranche, will be announced in due course.
This announcement does not
constitute, or form part of, an offer or any solicitation of an
offer for securities in any jurisdiction.
CONTACT DETAILS:
Contacts
Richard Joyce
+44 (0)7807
418516
Investor Relations
Catheryn O'Rourke
+44 (0) 1753 217 800
General Counsel & Company
Secretary
About Reckitt:
Reckitt* exists to protect, heal and
nurture in the relentless pursuit of a cleaner, healthier world. We
believe that access to the highest-quality hygiene, wellness and
nourishment is a right, not a privilege.
Reckitt is the company behind some of
the world's most recognisable and trusted consumer brands in
hygiene, health and nutrition, including Air Wick, Calgon, Cillit
Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic,
Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish,
Veet, Woolite and more.
Every day, more than 20 million
Reckitt products are bought globally. We always put consumers and
people first, seek out new opportunities, strive for excellence in
all that we do and build shared success with all our partners. We
aim to do the right thing, always.
We are a diverse global team of c.
40,000 colleagues. We draw on our collective energy to meet our
ambitions of purpose-led brands, a healthier planet and a fairer
society. Find out more, or get in touch with us
at www.reckitt.com
* Reckitt is the trading name of the
Reckitt Benckiser group of companies
Reckitt Benckiser Group plc's LEI
code is 5493003JFSMOJG48V108